Rare diseases
Investigational molecules
Locations
Study of lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa
CroatiaStudy of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors
CroatiaStudy on Lumateperone for Treating Manic Episodes in Bipolar I Disorder Patients
CroatiaStudy on How Concizumab Works for Patients with Hemophilia A or B with Inhibitors
CroatiaStudy on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
CroatiaStudy on Efgartigimod Alfa and Prednisone for Adults with Bullous Pemphigoid
CroatiaStudy on the Safety and Effectiveness of Ocrelizumab vs. Fingolimod for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis
CroatiaStudy Comparing Entrectinib and Crizotinib for Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Changes, With or Without Brain Metastases
CroatiaTitle: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis
CroatiaStudy on the Safety of Tiragolumab and Atezolizumab for Patients with Advanced or Metastatic Solid Tumors
CroatiaStudy on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure
CroatiaStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy
CroatiaTell us about your condition – we search every trial in Europe and connect you with the right site.
